Our results confirmed the increased mortality risk with the elevation of the inflammatory (C-reactive protein, serum ferritin, and LDH) and coagulation biomarkers (INR and D-dimer), anaemia, thrombocytopenia, leucocytosis, impaired hepatic and renal functions, and disturbance of electrolytes levels. This evidence concerns the gene CRP and Thrombocytopenia.